Transduced CD8+ T-cells with or without native TRAC disruption expressing HD_A-15 or HD_C-17 TCRs were then tested for recognition of primary 5T4+/HLA-A2+ RCC tumor cells versus autologous PTEC isolated from 4 donors (Supplementary Fig. 6). The gene discussed is CD8A; the disease is neoplasm.